Linda Song

Linda Song is a Scientist-II at Eikon Therapeutics, where Linda works on advancing drug discovery programs in oncology by measuring dynamics of target proteins in live cells. Previously, Linda was a Scientist-I at Kainomyx, focusing on developing small-molecule drugs for treating malaria and tropical diseases. Linda has also held positions at Stanford University School of Medicine, Santa Clara University, Dulwich College International, Harvard University, and Emmanuel College, where Linda has shown versatility in research, teaching, and mentoring roles. Linda holds a Ph.D. in Biophysics from Harvard University.